In less than a week a number of states will decide the fate of legalized or medical marijuana. While progress has been a long time coming locally there has been no sign marijuana will budge from its Schedule 1 status federally, which means that research into the plant’s therapeutic efficacy continues to suffer. It also means that the feds will keep intervening with state’s rights when they so choose. For a plant that humans have utilized for millennia—our brain’s endogenous cannabinoid receptors make us easy targets—restrictions are recent. In his book, Marijuana: A Short History, Brookings Institution senior fellow John Hudak points to the 1906 Federal Food and Drug Act as the beginning of what would become a series of legislative acts and fear-mongering campaigns associating marijuana with a variety of cognitive and bodily diseases, most of which are patently false.
